Tomorrow is Now
Make the present more future
40 %
CN
CN EN
About us
Sichuan Yuanda Shuyang Pharmaceutical Co., LTD. (hereinafter referred to as "Yuanda Shuyang") is a wholly-owned subsidiary of Yuanda Life Sciences Group Co., LTD. Its predecessor was the Plasma Institute of Logistics Department of Chengdu Military Region founded in 1969. In 1985, Chengdu Shuyang Pharmaceutical Factory was formally established. In 1998, the Logistics Department of the Chengdu Military Region transferred to the Chengdu People's Government, and joined China Broad Group in 2001. Over the past half century, Yuanda Shuyang has continued to forge ahead, innovate and develop, and has continued to deepen the field of blood products, and has become one of the leading high-tech enterprises with comprehensive strength in China's blood products industry. Based on the domestic and global perspective, Yuanda Shuyang continues to deepen the technological innovation and innovation of blood products, and has a modern blood products production base that covers the production demand of the whole product chain and is highly integrated with automation and information technology. The single production capacity ranks the forefront in China. With the industry technology innovation and innovation upgrade as a breakthrough, focusing on the product strategy of "pipeline diversification, layout iteration, variety combination, and field scale", Broad Shuyang constantly expands the product pipeline of blood products, layout reorganization, cell gene therapy and other products, and always adheres to the quality management concept of "one dose of medicine, two lives", and implements total quality management. Continuous improvement of product quality, to provide patients with safe, reliable and high-quality blood products. In the future, Yuanda Shuyang will adhere to the development path of "high quality standards, full product coverage and market internationalization", gather the development momentum of the industry, gather high-speed development forces, and strive to become "international high-quality service providers of the whole product chain in the field of blood products", protect human health, improve the quality of life, and create a better life.
more
  • 1500Tons of

    The scale of the new base

  • 2000People +

    Number of employees (including pulp station)

  • 17a

    Number of pulp stations

  • 20Billion Yuan +

    Cumulative investment in R&D

  • 50item

    Patent grant

  • 38years

    Establishment time

* Data as of November 13, 2023
Quartermaster Support Period (1969-1984)
  • 1969
Multiple Exploration Period (1985-2001)
  • 1985
  • 1989
  • 1994
  • 1998
  • 2001
Expanding and strengthening period (2001-2020)
  • 2003
  • 2004
  • 2007
  • 2011
  • 2016
  • 2019
  • 2021
Across the Board (2021 - present)
  • 2022
History
R&d innovation
Focus on blood-derived products and collaborate with biomedicine
more
Market layout
Adhering to the concept of "academic leadership, service first, management innovation", actively promote the construction of marketing "three" (standardization, information, digital), committed to the construction and operation of professional, standardized, efficient and fine academic service marketing system, and constantly enhance the core competitiveness of the market.
  • omni-channel

    Hospitals, businesses, pharmacies, primary medical institutions
  • Integrated marketing

    Point-to-point key account management point-to-point academic promotion platform multimedia digital marketing platform
International market
Deep cultivation of the international market for nearly 20 years, a total of 6 products have obtained export registration in 13 countries, and continue to achieve export sales in many countries in Asia, Eastern Europe, Central and South America.
  • 20 years

    Deeply cultivate the international market

  • six

    Product export

  • thirteen

    National export registration

Domestic market
Sales and academic promotion teams are set up according to treatment fields, focusing on the fields of hematology, hemostasis, immunization and critical care, and forming a professional, academic and high-execution sales organization. We have solid strategic partners, stable high-quality cooperative customers, sound customer network and substantial market resources.
  • 100 people +

    Academic management team

  • twenty-eight

    Province/region/Municipality

  • 3000家+

    medical institution

Global
News information
Shuyang story